Beneficial ownership (Redmile/Green)
10,019,421 shares (9.9%)
Common stock beneficially owned as of July 17, 2026
Beneficial ownership (RBI II)
8,125,342 shares (8.1%)
Common stock beneficially owned by Redmile Biopharma Investments II, L.P.
Open-market purchase
143,808 shares at ~$7.46 per share
Shares bought on July 17, 2026 using about $1,000,000 of working capital
Shares held by Redmile funds
5,233,076 shares
Common stock directly held by Redmile funds, including RBI II
Shares from pre-funded warrants (counted)
4,786,345 shares
Maximum issuable under 9.99% Beneficial Ownership Limitation included in ownership
Total warrant underlying shares
10,943,951 shares
Common shares underlying all pre-funded warrants held by Redmile funds
Stock options included
146,086 shares
Shares subject to options exercisable within 60 days, held by a former director as nominee
Shares outstanding baseline
95,508,165 shares
Common stock outstanding after underwritten offering used for percentage calculations